申请人:FLORATEK PHARMA AG
公开号:US20220402889A1
公开(公告)日:2022-12-22
The present invention concerns compounds of Formula (1), pharmaceutically acceptable salts, solvates or prodrugs thereof, pharmaceutical compositions comprising the same, and the use of the same in treating or preventing a disease.